Skip to main content

Heme Oxygenase-1 and Alzheimer Disease

  • Chapter
Heme Oxygenase in Biology and Medicine

Abstract

Alzheimer disease (AD) is a dementing illness characterized by progressive neuronal degeneration, gliosis, and the accumulation of intracellular inclusions (neurofibrillary tangles) and extracellular deposits of amyloid (senile plaques) in discrete regions of the basal forebrain, hippocampus, and association cortices (Selkoe, 1991). Sporadic AD is more common than all other aging-related neurodegenerative disorders combined, affecting approximately 5–10% of North Americans aged 65 and as many as 30–50% of those who survive to the end of their ninth decade (Katzman, 1993).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abraham N., 1998. Quantitation of Heme Oxygenase (HO-1) copies in human tissues by competitive RT/PCR. In: Armstrong D., ed. Methods in Molecular Biology, 108: Free Radical and Antioxidant Protocols. Humana Press, Totowa, NJ. pp. 199–209.

    Chapter  Google Scholar 

  • Applegate L.A., Luscher P., and Tyrrell R.M., 1991. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res. 51:974–978.

    PubMed  CAS  Google Scholar 

  • Baranano D.E., Doré S., Ferris C.D., and Snyder S.H., 2001. Physiological roles for the heme oxygenase products carbon monoxide, bilirubin and iron: links to neuroprotection in stroke and Alzheimer’s disease. Clin. Neurosci. Res. 1:46–52.

    Article  CAS  Google Scholar 

  • Beal M.F., 1995. Mitochondrial Dysfunction and Oxidative Damage in Neurodegenerative Diseases. Landes, Austin. pp. 1–128.

    Google Scholar 

  • Beschorner R., Adjodah D., Schwab J.M., Mattern R., Schluesener H.J., and Meyermann R., 2000. Long- term expression of heme oxygenase-1 (HO-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropath. 100:377–384.

    Article  PubMed  CAS  Google Scholar 

  • Cavanaugh J.B., 1999. Corpora amylacea and the family of polyglucosan diseases. Brain Res. Rev. 29:265–295.

    Article  Google Scholar 

  • Chen K., Gunter K., and Maines M.D., 2000. Neurons overexpressing heme oxygenase-1 resist oxidative stress-mediated cell death. J. Neurochem. 75:304–313.

    Article  PubMed  CAS  Google Scholar 

  • Cissé S. and Schipper H.M., 1995. Experimental induction of corpora amylacea-like inclusions in rat astroglia. Neuropath. Appl. Neurobiol. 21:423–431.

    Article  Google Scholar 

  • Doré S., Takahashi M., Ferris C.D., Hester L.D., Guastella D., and Snyder S.H., 1999. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl Acad. Sci., USA. 96:2445–2450.

    Article  PubMed  Google Scholar 

  • Doty R.L., 1991. Olfactory dysfunction in neurodegenerative disorders. In: Getchell T.V., Doty R.L., Bartoshuk L.M., Snow Jr. J.B. (Eds.). Smell and Taste in Health and Disease, Raven, New York. pp. 735–751.

    Google Scholar 

  • Dwyer B.E., Nishimura R.N., and Lu S.-Y., 1995. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Mol. Brain Res. 30:37–47.

    Article  PubMed  CAS  Google Scholar 

  • Ewing J.F. and Maines M.D., 1991. Rapid induction of heme oxygenase 1 mRNA and protein by hyperthermia in rat brain: heme oxygenase 2 is not a heat shock protein. Proc. Natl Acad. Sci., USA. 88:5364–5368.

    Article  PubMed  CAS  Google Scholar 

  • Ewing J.F., Haber S.N., and Maines M.D., 1992. Normal and heat-induced patterns of expression of heme oxygenase-1 (HSP32) in rat brain: hyperthermia causes rapid induction of mRNA and protein. J. Neurochem. 58:1140–1149.

    Article  PubMed  CAS  Google Scholar 

  • Frankel D. and Schipper H.M., 1999. Cysteamine pre-treatment of the astroglial substratum (mitochon-drial iron sequestration) enhances PC12 cell vulnerability to oxidative injury. Exp. Neurol. 160:376–385.

    Article  PubMed  CAS  Google Scholar 

  • Frankel D., Mehindate K., and Schipper H.M., 2000. Role of heme oxygenase-1 in the regulation of manganese superoxide dismutase gene expression in oxidatively-challenged astroglia. J. Cell. Physiol. 185:80–86.

    Article  PubMed  CAS  Google Scholar 

  • Fukuda K., Richmon J.D., Sato M., Sharp F.R., Panter S.S., and Noble L.J., 1996. Induction of heme oxygenase-1 (HO-1) in glia after traumatic brain injury. Brain Res. 736:68–75.

    Article  PubMed  CAS  Google Scholar 

  • Galbraith R., 1999. Heme oxygenase: who needs it?. PSEBM. 222:299–305.

    Article  CAS  Google Scholar 

  • Ham D. and Schipper H.M., 2000. Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides. Cell. Mol. Biol. 46:587–596.

    PubMed  CAS  Google Scholar 

  • Jefferies W.A., Food M.R., Gabathuler R., Rothenberger S., Yamada T., Yasuhara O., and McGeer PL.,1996. Reactive microglia specifically associated with amyloid plaques in Alzheimer’s disease brain tissue express melanotransferrin. Brain Res. 712:122–126.

    Article  PubMed  CAS  Google Scholar 

  • Kadoya C., Domino E.F., Yang G.Y., Stern J.D., and Betz A.L., 1995. Preischemic but not postischemic zinc protoporphyrin treatment reduces infarct size and edema accumulation after temporary focal cerebral ischemia in rats. Stroke. 26:1035–1038.

    Article  PubMed  CAS  Google Scholar 

  • Katzman R.L., 1993. Education and the prevalence of dementia and Alzheimer’s disease. Neurology. 43:13–20.

    Article  PubMed  CAS  Google Scholar 

  • Kimpara T., Takeda A., Watanabe K., Itoyama Y., Ikawa S., Watanabe M., Arai H., Sasaki H., Higuchi S., Okita N., Takase S., Saito H., Takahashi K., and Shibahara S., 1997. Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum. Genet. 100:145–147.

    Article  PubMed  CAS  Google Scholar 

  • Koeppen A.H. and Dickson A.C., 1999. Neuroprotection in intracerebral hemorrhage with tin-protoporphyrin. Ann. Neurol. 46:938.

    Google Scholar 

  • Le W., Xie W., and Appel S., 1999. Protective role of heme oxygenase-1 in oxidative stress-induced neuronal injury. J. Neurosci. Res. 56:652–658.

    Article  PubMed  CAS  Google Scholar 

  • Liebson E. and Albert M., 1994. Cognitive changes in dementia of the Alzheimer type. In: Calne D.B. (Ed.). Neurodegenerative Diseases, Saunders, Philadelphia. pp. 615–629.

    Google Scholar 

  • Llesuy S.F. and Tomaro M.L., 1994. Heme oxygenase and oxidative stress. Evidence of involvement of bilirubin as physiological protector against oxidative damage. Biochem. Biophys. Acta. 1223:9–14.

    Article  PubMed  CAS  Google Scholar 

  • Lowe J., Errington D.R., Lennox G., Pike I., Spendlove I., Landon M., and Mayer R.J., 1992. Ballooned neurons in several neurodegenerative diseases and stroke contain ß-crystallin. Neuropathol. Appl. Neurobiol. 18:341–350.

    Article  PubMed  CAS  Google Scholar 

  • Maines M., Polevoda B., Coban T., Johnson K., Stoliar S., Huang T.J., Panahian N., Cory-Slechta D.A., and McCoubrey W.K. Jr., 1998. Neuronal overexpression of heme oxygenase-1 correlates with an attenuated exploratory behavior and causes an increase in neuronal NADPH diaphorase staining. J. Neurochem. 70:2057–2069.

    Article  PubMed  CAS  Google Scholar 

  • Manganaro F., Chopra VS., Mydlarski M.B., Bernatchez G., and Schipper H.M., 1995. Redox perturbations in cysteamine-stressed astroglia: implications for inclusion formation and gliosis in the aging brain. Free Radic. Biol. Med. 19:823–835.

    Article  PubMed  CAS  Google Scholar 

  • Marks G., Brien J., Nakatsu K., and McLaughlin B., 1991. Does carbon monoxide have a physiological function?. Trends Pharmacol. Sci. 12:185–188.

    Article  PubMed  CAS  Google Scholar 

  • Mattson M.P., 1997. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77:1081–1132.

    PubMed  CAS  Google Scholar 

  • Matz P., Turner C., Weinstein P.R., Massa S.M., Panter S.S., and Sharp F.R., 1996. Heme oxygenase-1 induction in glia throughout rat brain following experimental subarachnoid hemorrhage. Brain Res. 713:211–222.

    Article  PubMed  CAS  Google Scholar 

  • Mecocci P., Polidori M.C., Ingegni T., Cherubini A., Chionne F., Cecchetti R., and Senin U., 1998. Oxidative damage to DNA in lymphocytes from AD patients. Neurology. 51:1014–1017.

    Article  PubMed  CAS  Google Scholar 

  • Mehindate K., Sahlas D.J., Frankel D., Mawal Y., Liberman A., Corcos J., Dion S., and Schipper H.M., 2001. Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J. Neurochem. 77:1387–1396.

    Article  Google Scholar 

  • Nakagami T., Toyomura K., Kinoshita T., and Morisawa S., 1993. A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochem. Biophys. Acta. 1158:189–193.

    Article  PubMed  CAS  Google Scholar 

  • Panahian N., Yoshiura M., and Maines M.D., 1999. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J. Neurochem. 72:1187–1203.

    Article  PubMed  CAS  Google Scholar 

  • Panizzon K.L., Dwyer B.E., Nishimura R.N., and Wallis R.A., 1996. Neuroprotection against CA1 injury with metalloporphyrins. NeuroReport. 7:662–666.

    Article  PubMed  CAS  Google Scholar 

  • Parks D., Kasckow J., and Vale W., 1994. Carbon monoxide modulates secretion of corticotropin-releasing factor from rat hypothalamic cell cultures. Brain Res. 646:315–318.

    Article  Google Scholar 

  • Percy M., Andrews D.F., and Potter H., 2000. Peripheral markers in Alzheimer’s disease. In: Scinto L.F.M.,Daffner K.R. (Eds.). Early Diagnosis of Alzheimer’s Disease. Humana Press, Totowa, NJ. pp. 191–268.

    Chapter  Google Scholar 

  • Perez N., Sugar J., Charya S., Johnson G., Merril C., Bierer L., Perl D., Haroutunian V., and Wallace W.,1991. Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer’s disease. Mol. Brain Res. 11:249–254.

    Article  PubMed  CAS  Google Scholar 

  • Premkumar D.R., Smith M.A., Richey P.L., Petersen R.B., Castellani R., Kutty R.K., Wiggert B., Perry G., and Kalaria R.N., 1995. Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer’s disease. J. Neurochem. 65:1399–402.

    Article  PubMed  CAS  Google Scholar 

  • Qato M.K. and Maines M.D., 1985. Prevention of neonatal hyperbilirubinaemia in non-human primates by Zn-protoporphyrin. Biochem. J. 226:51–57.

    PubMed  CAS  Google Scholar 

  • Reichmann H. and Riederer P., 1994. Mitochondrial disturbances in neurodegeneration. In: Calne D.B. (Ed.). Neurodegenerative Diseases, Saunders, Philadelphia. pp. 195–204.

    Google Scholar 

  • Renkawek K., Bosman G.C.G.M., and Gaestel M., 1993. Increased expression of heat-shock protein 27 kDa in Alzheimer disease: a preliminary study. NeuroReport. 5:14–16.

    Article  PubMed  CAS  Google Scholar 

  • Sahlas D.J., Liberman A., and Schipper H.M., 2000. Role of heme oxygenase-1 in the formation of corpora amylacea. Can. J. Neurol. Sci. 27(Suppl 2):S65–S66.

    Google Scholar 

  • Sapolsky R.M., 1992. Is this relevant to the human? In: Stress, the Aging Brain, and the Mechanisms of Neuron Death. MIT Press, Cambridge, MA. pp. 305–339.

    Google Scholar 

  • Sayre L.M., Smith M.A., and Perry G., 2001. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8:721–738.

    Article  PubMed  CAS  Google Scholar 

  • Schipper H.M., Kotake Y., and Janzen E.G., 1991. Catechol oxidation by peroxidase-positive astrocytes in primary culture: an electron spin resonance study. J. Neurosci. 11:2170–2176.

    PubMed  CAS  Google Scholar 

  • Schipper H.M., Cissé S., and Stopa E.G., 1995. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37:758–768.

    Article  PubMed  CAS  Google Scholar 

  • Schipper H.M., 1998a. Glial iron sequestration and neurodegeneration. In: Schipper H.M. (Ed.). Astrocytes in Brain Aging and Neurodegeneration, Landes, Austin. pp. 235–251.

    Google Scholar 

  • Schipper H.M., 1998b. Experimental induction of corpora amylacea in adult rat brain. Microsc. Res. Tech. 43:43–48.

    Article  PubMed  CAS  Google Scholar 

  • Schipper H.M., 1999. Glial HO-1 expression, iron deposition and oxidative stress in neurodegenerative diseases. Neurotox. Res. 1:57–70.

    Article  PubMed  CAS  Google Scholar 

  • Schipper H.M., Bernier L., Mehindate K., and Frankel D., 1999. Mitochondrial iron sequestration in dopamine-challenged astroglia: role of heme oxygenase-1 and the permeability transition pore. J. Neurochem. 72:1802–1811.

    Article  PubMed  CAS  Google Scholar 

  • Schipper H.M., Chertkow H., Mehindate K., Frankel D., Melmed C., and Bergman H., 2000. Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic Alzheimer disease. Neurology. 54:1297–1304.

    Article  PubMed  CAS  Google Scholar 

  • Schipper H.M., Mawal, Y., Cherkow H., and Bergman H., (in press). HO-1 mRNA in AD and MCI. Neurology.

    Google Scholar 

  • Selkoe D.J., 1991. The molecular pathology of Alzheimer’s disease. Neuron. 6:487–498.

    Article  PubMed  CAS  Google Scholar 

  • Smith M.A., Kutty R.K., Richey P.L., Yan S.-D., Stern D., Chader G.J., Wiggert B., Petersen R.B., and Perry G., 1994. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer’s disease. Am. J. Pathol. 145:42–47.

    PubMed  CAS  Google Scholar 

  • Snyder S.H., Jaffrey S.R., and Zakhary R., 1998. Nitric oxide and carbon monoxide; Parallel roles as neural messengers. Brain Res. Rev. 26:167–175.

    Article  PubMed  CAS  Google Scholar 

  • Stevens C. and Wang Y., 1993. Reversal of long-term potentiation by inhibitors of heme oxygenase. Nature. 364:147–149.

    Article  PubMed  CAS  Google Scholar 

  • Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., and Ames B.N., 1987. Bilirubin is an antioxidant of possible physiological importance. Science. 235:1043–1046.

    Article  PubMed  CAS  Google Scholar 

  • Suttner D.M. and Dennery P.A., 1999. Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB. J. 13:1800–1809.

    PubMed  CAS  Google Scholar 

  • Suzuki H., Kanamaru K., Tsunoda H., Inada H., Kuroki M., Sun H., Waga S., and Tanaka T., 1999. Heme oxygenase-1 gene induction as an intrinsic regulation against delayed cerebral vasospasm in rats. J. Clin. Invest. 104:59–66.

    Article  PubMed  CAS  Google Scholar 

  • Tanaka T., Nishimura Y., Tsunoda H., and Naka M., 2000. Pharmacogenomics and therapeutic target validation in cerebral vasospasm. J. Cardiovasc. Pharma. 36(Suppl 2):S1–S4.

    Article  CAS  Google Scholar 

  • Takahashi M., Doré S., Ferris C.D., Tomita T., Sawa A., Wolosker H., Borchelt D.R., Iwatsubo T., Kim S.-H., Thinakaran G., Sisodia S.S., and Snyder S.H., 2000. Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer’s disease. Neuron. 28:461–473.

    Article  PubMed  CAS  Google Scholar 

  • Takeda A., Perry G., Abraham N.G., Dwyer B.E., Kutty R.K., Laitinen J.T., Petersen R.B., and Smith M.A., 2000. Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J. Biol. Chem. 275:5395–5399.

    Article  PubMed  CAS  Google Scholar 

  • Tenhunen R., Marver H.S., and Schmid R., 1969. Microsomal heme oxygenase: characterization of the enzyme. J. Biol. Chem. 244:6388–6394.

    PubMed  CAS  Google Scholar 

  • Verma A., Hirsch D.J., Glatt C.E., Ronnett G.B., and Snyder S.H., 1993. Carbon monoxide: a putative neural messenger. Science. 259:381–384.

    Article  PubMed  CAS  Google Scholar 

  • Wang G.P., Khatoon S., Iqbal K., and Grundke-Iqbal I., 1991. Brain ubiquitin is markedly elevated in Alzheimer disease. Brain Res. 566:146–151.

    Article  PubMed  CAS  Google Scholar 

  • Zhang J. and Piantadosi C.A., 1992. Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J. Clin. Invest. 90:1193–1199.

    Article  PubMed  CAS  Google Scholar 

  • Zhuo M., Small S., Kandel E., and Hawkins R., 1993. Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus. Science. 260:1946–1950.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Mawal, Y., Berlin, D., Kravitz, S., Schipper, H.M. (2002). Heme Oxygenase-1 and Alzheimer Disease. In: Abraham, N.G. (eds) Heme Oxygenase in Biology and Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0741-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0741-3_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5219-8

  • Online ISBN: 978-1-4615-0741-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics